Wyeth Licenses Hedgehog Technology for Nervous Disorders
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 45 (Table of Contents)
Published: 4 Mar-2004
DOI: 10.3833/pdr.v2004.i45.823 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Curis licensed its small molecule Hedgehog pathway agonists to Wyeth Pharmaceuticals for the treatment of neurological disorders, including Parkinson’s disease and stroke...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS